Optimization of the Ocular Surface Through Treatment of Ocular Surface Disease Before Ophthalmic Surgery: A Narrative Review.
Barry A SchechterFrancis MahPublished in: Ophthalmology and therapy (2022)
Ocular surface disease commonly exists in individuals requiring ophthalmic surgery and may compromise the structure and function of ocular surface components. Ophthalmic surgery may further affect the ocular surface by injuring the epithelium and sensory nerves, disrupting the tear film, or causing local inflammation. Medical management of ocular surface disease prior to ophthalmic surgery aids in reducing inflammation, resolving infection, improving epithelial pathology, stabilizing the tear film, and easing patient symptoms, promoting positive long-term outcomes and minimizing the incidence of postoperative complications. This review summarizes frequently encountered ocular surface diseases and available preoperative medical management options, discusses common ophthalmic surgeries and their effects on the ocular surface, examines potential postoperative complications, and defines recommendations for postoperative ocular surface maintenance.
Keyphrases
- minimally invasive
- coronary artery bypass
- surgical site infection
- healthcare
- oxidative stress
- patients undergoing
- physical activity
- risk factors
- gold nanoparticles
- case report
- coronary artery disease
- acute coronary syndrome
- depressive symptoms
- reduced graphene oxide
- clinical practice
- combination therapy
- climate change
- sleep quality